Page last updated: 2024-08-24

sertraline and Medulloblastoma

sertraline has been researched along with Medulloblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukunishi, Y; Hirao, Y; Kurita, JI; Nakano, H; Nishimura, Y	1

Other Studies

1 other study(ies) available for sertraline and Medulloblastoma

Article	Year
Sertraline, chlorprothixene, and chlorpromazine characteristically interact with the REST-binding site of the corepressor mSin3, showing medulloblastoma cell growth inhibitory activities. Scientific reports, 2018, 09-13, Volume: 8, Issue:1 Topics: Animals; Binding Sites; Cell Proliferation; Chlorpromazine; Chlorprothixene; Humans; Medulloblastoma; Mice; Protein Binding; Protein Domains; Repressor Proteins; Serotonin Plasma Membrane Transport Proteins; Sertraline	2018

Article

Year

Sertraline, chlorprothixene, and chlorpromazine characteristically interact with the REST-binding site of the corepressor mSin3, showing medulloblastoma cell growth inhibitory activities.

Scientific reports, 2018, 09-13, Volume: 8, Issue:1

Topics: Animals; Binding Sites; Cell Proliferation; Chlorpromazine; Chlorprothixene; Humans; Medulloblastoma; Mice; Protein Binding; Protein Domains; Repressor Proteins; Serotonin Plasma Membrane Transport Proteins; Sertraline

2018